Vanguard Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $47.1M | Buy |
|
|||||
|
2025
Q1 | $18.1M | Sell |
|
|||||
|
2024
Q4 | $22.6M | Buy |
|
|||||
|
2024
Q3 | $19.4M | Sell |
|
|||||
|
2024
Q2 | $25.7M | Sell |
|
|||||
|
2024
Q1 | $84.1M | Buy |
|
|||||
|
2023
Q4 | $76.3M | Buy |
|
|||||
|
2023
Q3 | $64.1M | Buy |
|
|||||
|
2023
Q2 | $76.7M | Buy |
|
|||||
|
2023
Q1 | $55.9M | Buy |
|
|||||
|
2022
Q4 | $73.8M | Buy |
|
|||||
|
2022
Q3 | $126M | Buy |
|
|||||
|
2022
Q2 | $35.8M | Buy |
|
|||||
|
2022
Q1 | $52.9M | Buy |
|
|||||
|
2021
Q4 | $50.3M | Buy |
|
|||||
|
2021
Q3 | $60.3M | Buy |
|
|||||
|
2021
Q2 | $3.92M | Buy |
|